TRIO is a unique, full-service oncology clinical research organization (CRO) that leverages the strengths of our worldwide network of Investigators, academic leaders, patient advocates and our clinical research team to accelerate drug development. We’ve spent decades conducting oncology trials from inception to completion, focusing on the best research and science to guide the development of innovative and biologically sound therapies. This translational research model allows us to bring targeted concepts into clinics on the most rational development path. We find the shortest course to save lives. We are focused. We care. We deliver.
View Top Employees from TRIO - Translational Research in OncologyWebsite | http://www.trioncology.org |
Employees | 242 (222 on RocketReach) |
Founded | 1997 |
Address | Suite 1100, 9925-109 Street, Edmonton, Alberta T5K 2J8, CA |
Phone | (780) 702-0200 |
Fax | (780) 702-0190 |
Technologies |
JavaScript,
HTML,
PHP
+39 more
(view full list)
|
Industry | Research Services, Translational Research, Oncology, Clinical Trials (Phase I, II and III) |
Web Rank | 4 Million |
Keywords | Translational Research, Drug Development And Manufacturing, Targeted Cancer Therapies, Clinical Trials, Patient Recruitment Services, Regulatory Compliance |
Looking for a particular TRIO - Translational Research in Oncology employee's phone or email?
Catherine Marle is the CEO of TRIO - Translational Research in Oncology.
222 people are employed at TRIO - Translational Research in Oncology.
TRIO - Translational Research in Oncology is based in Edmonton, Alberta.